Dr. Nancy A. Rigotti, MD
Professor of Medicine, Harvard Medical School
Director, Tobacco Research & Treatment Center, Massachusetts General Hospital, Boston
Nancy Rigotti, MD, is a Professor of Medicine at Harvard Medical School, Associate Chief of the Division of General Internal Medicine at Massachusetts General Hospital (MGH), founder and director of MGH’s Tobacco Research and Treatment Center, as well as Past President of the Society for Research in Nicotine and Tobacco and Past President of the Society of General Internal Medicine. Dr. Rigotti is known for her leadership to incorporate the delivery of tobacco use treatment into routine health care delivery settings. She led JAMA’s 2022 Clinical Review, Treatment of Tobacco Use and co-led the American College of Cardiology’s Consensus Decision Pathway on Tobacco Cessation Treatment. Her research includes evaluations of tobacco control public policies, clinical trials of behavioral and pharmacologic smoking cessation treatments, and evaluation of system-level interventions for various inpatient and outpatient health care settings in the U.S. and globally. Dr. Rigotti was a member of the committee that produced the 2018 U.S. National Academies of Science, Engineering, and Medicine Report, Public Health Consequences of Electronic Cigarettes. Her subsequent research on this topic has addressed the role of e-cigarettes for smoking cessation and harm reduction and interventions to assist e-cigarette users to quit.
- What doctors say…and what patients hear: Should e-cigarettes be more widely recommended as a smoking cessation aid?
May 16 2023 2:30 pm
- Panel Discussion and Q&A
May 16 2023 2:45 pm